Fulcrum repurposes failed GSK drug for rare diseaseGSK’s failed cardiovascular drug losmapimod looks like it might get a new lease of life after being picked Share XFulcrum repurposes failed GSK drug for rare diseasehttps://pharmaphorum.com/news/fulcrum-repurposes-failed-gsk-drug-for-rare-disease/
Psoriasis and cardio drugs drive Novartis’ Q1 salesNovartis has begun 2019 at a sprint, upgrading its sales forecasts for the year after strong performances from Share XPsoriasis and cardio drugs drive Novartis’ Q1 saleshttps://pharmaphorum.com/news/psoriasis-and-cardio-drugs-drive-novartis-q1-sales/
Pfizer/Lilly non-opioid pain drug shows more positive resultsResults from a new study of Pfizer and Lilly’s non-opioid pain drug tanezumab have shown that it can Share XPfizer/Lilly non-opioid pain drug shows more positive resultshttps://pharmaphorum.com/news/pfizer-lilly-non-opioid-pain-drug-shows-more-positive-results/
Alexa: Tell me about Amazon’s ambitions in healthcareOver the last two years Amazon’s healthcare plans have gone from being a closely guarded secret to underpinning Share XAlexa: Tell me about Amazon’s ambitions in healthcarehttps://pharmaphorum.com/digital/amazon-alexa-haven-healthcare/
Strength in numbers: Because having a rare disease isn’t rareRare doesn’t mean insignificant – in fact more people live with a rare disease than with cancer and Share XStrength in numbers: Because having a rare disease isn’t rarehttps://deep-dive.pharmaphorum.com/magazine/pharma-research-rare-diseases/global-genes-rare-diseases/
Transparency creates fruitful pharma-patient group partnershipsCollaboration between pharma and patient organisations can yield fantastic results – but conflict of interest concerns can stop Share XTransparency creates fruitful pharma-patient group partnershipshttps://pharmaphorum.com/views-analysis-patients/transparency-creates-fruitful-pharma-patient-group-partnerships/
Deep Dive: R&D InnovationIn this issue of Deep Dive we look at innovation in pharma R&D, asking how can pharmaceutical companies Share XDeep Dive: R&D Innovationhttps://pharmaphorum.com/r-d/pharma-research-rare-diseases-0219/
Deep Dive: Disruptive TechnologiesIn the first issue of Deep Dive for 2019, we look at disruptive technologies in pharma, how they’re Share XDeep Dive: Disruptive Technologieshttps://pharmaphorum.com/digital/disruptive-technologies-pharma-2019/
European digital health innovationHealthcare and the pharmaceutical industry are redefining their roles for the modern age as digital health tech radically Share XEuropean digital health innovationhttps://pharmaphorum.com/digital/european-digital-health-innovation/
Navigating new frontiers: Ways to find space in the future RA market Share XNavigating new frontiers: Ways to find space in the future RA markethttps://pharmaphorum.com/r-d/navigating-new-frontiers-ways-to-find-space-in-the-future-ra-market/
The 2nd Life Sciences Sector Deal and the NHS 10 Year Plan Share XThe 2nd Life Sciences Sector Deal and the NHS 10 Year Planhttps://pharmaphorum.com/market-access-2/the-2nd-life-sciences-sector-deal-and-the-nhs-10-year-plan/
Cancer, genomics and personalised medicine: Modelling oncology’s future Share XCancer, genomics and personalised medicine: Modelling oncology’s futurehttps://pharmaphorum.com/oncology/cancer-genomics-and-personalised-medicine-modelling-the-future-of-oncology/
Breaking new ground in digital content delivery for pharmaIt’s all too easy for pharmaceutical processes to slow marketing campaigns, rendering them unmanageable and ineffective, but a Share XBreaking new ground in digital content delivery for pharmahttps://pharmaphorum.com/sales-marketing/breaking-new-ground-in-digital-content-delivery-for-pharma/
Good data supports pharma sales reps to drive lead generationAllow pharma sales reps to focus on the job in hand by making sure they have access to Share XGood data supports pharma sales reps to drive lead generationhttps://pharmaphorum.com/sales-marketing/good-data-supports-pharma-sales-reps-to-drive-lead-generation/
An integrated CRM saves time, money and drives sales efficiencyLike most pharmaceutical companies, Théa Pharma places the utmost importance on quality customer data – but non-integrated systems were Share XAn integrated CRM saves time, money and drives sales efficiencyhttps://pharmaphorum.com/sales-marketing/an-integrated-crm-saves-time-money-and-drives-sales-efficiency/
GSK and digital disruption: the pharmaphorum podcast Share XGSK and digital disruption: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/gsk-digital-disruption
The future of pharma in a digital world Share XThe future of pharma in a digital worldhttps://pharmaphorum.com/digital/healthlive-the-future-of-pharma-in-a-digital-world/
Raising the bar in liver cancer therapy Share XRaising the bar in liver cancer therapyhttps://pharmaphorum.com/oncology/insights-oncology/raising-bar-liver-cancer-therapy/
Healthcare Artificial Intelligence Market will surge at 41% CAGR up to 2025 Share XHealthcare Artificial Intelligence Market will surge at 41% CAGR up to 2025https://pharmaphorum.com/partner-content/healthcare-artificial-intelligence-market-will-surge-at-41-cagr-up-to-2025/
Healthcare Analytics Market will surpass $18 Billion by 2025 Share XHealthcare Analytics Market will surpass $18 Billion by 2025https://pharmaphorum.com/partner-content/healthcare-analytics-market-will-surpass-18-billion-by-2025/
Invite from Ziva Abraham Chair – SMi’s 3rd Annual Pharma Microbiology Share XInvite from Ziva Abraham Chair – SMi’s 3rd Annual Pharma Microbiologyhttps://pharmaphorum.com/partner-content/invite-from-ziva-abraham-chair-smis-3rd-annual-pharma-microbiology/
Save the date for SMi’s 10th Annual Biosimilars Conference 2019 Share XSave the date for SMi’s 10th Annual Biosimilars Conference 2019https://pharmaphorum.com/partner-content/save-the-date-for-smis-10th-annual-biosimilars-conference-2019/
pharmaphorum welcomes George Underwood to its editorial helm Share Xpharmaphorum welcomes George Underwood to its editorial helmhttps://pharmaphorum.com/news/pharmaphorum-welcomes-george-underwood-to-its-editorial-helm/
STEM Healthcare appoints Jason McKenna as CEO Share XSTEM Healthcare appoints Jason McKenna as CEOhttps://pharmaphorum.com/partner-content/stem-healthcare-appoints-jason-mckenna-as-ceo/
